AO
Angelis Oncology, Inc.
SEC filingBiotechnology · San Francisco, CA
Amount raised$400Ksold at filing
Total offeringNot stated
Investors in the raise1count reported to the SEC
FiledJul 23, 2026first sale Jul 10, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Daniel SantiExecutive Officer, Director
Executive officers, directors and promoters as listed on the Form D.